Results 141 to 150 of about 98,994 (359)
Central Nervous System Tumors in Xeroderma Pigmentosum: Five Cases and Review of the Literature
Movement Disorders, EarlyView.Abstract Background Xeroderma pigmentosum (XP) is a rare autosomal recessive DNA‐repair disorder characterized by extreme ultraviolet radiation (UVR) sensitivity, markedly increased cutaneous malignancy risk, and progressive neurological disease in approximately one‐third of patients.
Farrah S. Bakr +4 more
wiley +1 more source
A population-based study of familial cutaneous melanoma
, 2001 We studied familial risks in cutaneous melanoma by comparing the occurrence of melanoma, or discordant cancer, in two generations, based on the Swedish Family-Cancer Database of 9.6 million individuals. Offspring were from 0 to 61 years of age.
Hemminki, K,, Lonnstedt, I, Vaittinen, P
core
, 2006 The induction of angiogenesis is crucial in the development of most human tumors. Angiogenesis is routinely assessed by the density of tumor microvessels.
van de Winkel, Anouk +5 more
core +1 more source
Conjunctival Involvement in a Patient with Cutaneous Malignant Melanoma [PDF]
, 2002 Levent Filik, Tuğba Oskay, O. Ozyilkan
openalex +1 more source
Medicine Advances, EarlyView.This study demonstrated a clear association between serine protease inhibitor (SERPIN) gene alterations and clinical outcomes in patients with melanoma and non‐small cell lung cancer receiving immune checkpoint inhibitor therapy across five cohorts.
Jieqiong Li +5 more
wiley +1 more source
Citotoxicidade de derivados maleimídicos: relação entre a atividade antitumoral e antiadipogênica [PDF]
, 2014 Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Programa de Pós-Graduação em Farmácia, Florianópolis, 2014.O câncer é caracterizado pelo crescimento descontrolado de células que invadem o tecido circundante e
Rosolen, Daiane
core
, 2006 Penile involvement has been implicated as a metastatic site in several tumors; approximately 300 cases have been reported. Of these, only two cases showed cutaneous melanoma as the primary site.
Tas, Faruk, Aykan, Faruk, Kurul, Sidika
core +1 more source
Effectiveness and Safety of Setmelanotide in a Patient With a Heterozygous PCSK1 Deficiency
Obesity, EarlyView.ABSTRACT Setmelanotide, a melanocortin 4 receptor (MC4R) agonist, is a promising pharmacological treatment option for people with rare monogenic obesity conditions affecting the leptin‐melanocortin signaling pathway, including proprotein convertase subtilisin/kexin type 1 (PCSK1) gene mutations.
Ellina Lytvyak +2 more
wiley +1 more source